Product NDC: | 0186-0016 |
Proprietary Name: | ATACAND |
Non Proprietary Name: | Candesartan cilexetil |
Active Ingredient(s): | 16 mg/1 & nbsp; Candesartan cilexetil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0186-0016 |
Labeler Name: | AstraZeneca LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020838 |
Marketing Category: | NDA |
Start Marketing Date: | 19980914 |
Package NDC: | 0186-0016-28 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0186-0016-28) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 0186-0016-28 |
Proprietary Name | ATACAND |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0186-0016-28) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 0186-0016 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Candesartan cilexetil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19980914 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca LP |
Substance Name | CANDESARTAN CILEXETIL |
Strength Number | 16 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |